J
José Luis Zamorano
Researcher at Carlos III Health Institute
Publications - 740
Citations - 154643
José Luis Zamorano is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 105, co-authored 695 publications receiving 133396 citations. Previous affiliations of José Luis Zamorano include Hospital Clínico San Carlos & Universidad Francisco de Vitoria.
Papers
More filters
Journal Article
Wireless echocardiography: a step towards the future.
Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
Christiaan Vrints,David A. Wood,José Luis Zamorano,Faiez Zannad,Sehnaz Karadeniz,Alessandro Mezzani,Eva Prescott,Shah Ebrahim,Giuseppe Germanò,Richard Hobbs,Pascale Benlian,G. Boysen,Ian Graham,Zeljko Reiner,W M Monique Verschuren,Guy De Backer,Helmut Gohlke +16 more
Journal ArticleDOI
Insuficiencia mitral isquémica e infarto agudo de miocardio sin elevación del segmento ST: implicaciones pronósticas a largo plazo
Iván J. Núñez Gil,Leopoldo Pérez de Isla,Juan C. García-Rubira,Antonio Fernández-Ortiz,Juan José González Ferrer,David Vivas,José Alberto de Agustín Loeches,Carlos Macaya,José Luis Zamorano +8 more
TL;DR: La IM deberia cuantificarse y seguirse en todo paciente tras un IAMSEST, y establece un peor pronostico a largo plazo.
Journal ArticleDOI
Assessment of cardiac viability by thallium 201 redistribution and dobutamine echocardiography
José Luis Zamorano,Juan F. Delgado,Carlos Almería,Miguel Angel Gomez Sanchez,Teresa Sotelo,Raúl Moreno,Enrique Meroño,Cristina Fernández,Rufilanchas Jj,Luis Sánchez-Harguindey +9 more
TL;DR: The discrepant results of dobutamine echocardiography and thallium 201 are due to differences in the minimum mass of live myocytes required by each technique to detect viability.
Journal ArticleDOI
Left Ventricular Geometric Patterns After 1 Year of Antihypertensive Treatment
M. Luque,Nieves Martell,Isabel Egocheaga,Carmen Fernandez-Pinilla,José Luis Zamorano,Carlos Almería,Arturo Fernández-Cruz,Carlos M. Ferrario +7 more
TL;DR: The data suggest that even while suboptimal antihypertensive treatment reduces left ventricular mass index, eitherleft ventricular hypertrophy or concentric remodeling remains present in a significant number of patients at the end of a 1‐year treatment period.